CRN's president and CEO, Steve Mister, on the new HHS

At the Future Nutra Innovation Summit, Sibyl Swift, PhD, founder and principal of Swift Strategy Group, discusses supplement oversight and unpacks why mandatory product listing divides the industry.

The inaugural Future Nutra Innovation Summit opened with organizers pitching a networking-first alternative to the traditional trade show, followed by an NSF presentation on certification failure rates and consumer trust that set a tone for the rest of the event.

At the Future Nutra Innovation Summit, PLT Health's Steve Fink discusses joint, cognitive, and longevity nutrition explaining why "experiential longevity" is reshaping formulation strategy.

Live from the Future Nutra Innovation Summit, Kerry Hughes, founder and president of Ethnopharm, explains why botanicals' complex compound networks represent nutrition's next innovation frontier.

Nammex is bringing its already-introduced ErinaPrime Lion's mane mycelium ingredient, standardized to a specific neuroactive compound, to SupplySide Global.

The Dietary Supplement Innovation Act, introduced by Rep. Harshbarger, would cap indefinite preclusion, require science-based review standards, and open FDA warnings to court challenge.

Paul Eftang used his FNIS session to walk through lab data on lion's mane and Tongkat Ali products that pass identity and DNA testing while containing few or none of the bioactive compounds their marketing claims are based on.

Live from the Future Nutra Innovation Summit, Amber Thelen, director of technical services and innovation at Purity-IQ discusses strain-level verification gaps, NMR testing, and viability PCR for probiotic testing.